IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.854
AS - Asia 3.004
EU - Europa 2.615
SA - Sud America 463
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 10.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.775
SG - Singapore 1.192
CN - Cina 1.009
IT - Italia 801
SE - Svezia 450
IE - Irlanda 424
BR - Brasile 369
HK - Hong Kong 283
FI - Finlandia 225
VN - Vietnam 206
DE - Germania 158
NL - Olanda 115
ZA - Sudafrica 109
FR - Francia 100
GB - Regno Unito 94
RU - Federazione Russa 69
TR - Turchia 64
UA - Ucraina 60
BD - Bangladesh 58
IN - India 52
CA - Canada 44
AR - Argentina 41
BE - Belgio 29
AT - Austria 25
MX - Messico 23
KR - Corea 19
PL - Polonia 18
ES - Italia 15
ID - Indonesia 15
JP - Giappone 15
EC - Ecuador 14
PK - Pakistan 12
IQ - Iraq 11
MA - Marocco 11
VE - Venezuela 11
CI - Costa d'Avorio 10
UZ - Uzbekistan 10
IR - Iran 9
LT - Lituania 9
CO - Colombia 8
IL - Israele 8
AZ - Azerbaigian 7
PE - Perù 7
EU - Europa 6
KE - Kenya 6
UY - Uruguay 6
EG - Egitto 5
TW - Taiwan 5
CL - Cile 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
LB - Libano 4
PT - Portogallo 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DK - Danimarca 3
GE - Georgia 3
LK - Sri Lanka 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
JM - Giamaica 2
JO - Giordania 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.099
Salva come PNG Salva come JPEG
Città #
Singapore 585
Ashburn 441
Dublin 413
Dallas 408
Santa Clara 381
Chandler 376
Beijing 280
Hong Kong 274
Parma 201
Ann Arbor 172
Boardman 157
Dearborn 142
Los Angeles 115
Johannesburg 98
New York 89
Shanghai 88
Jacksonville 83
Nanjing 79
Ho Chi Minh City 77
Hefei 75
Princeton 69
Izmir 54
Moscow 44
Wilmington 43
Bologna 39
Milan 39
Columbus 38
Munich 36
Hanoi 34
Helsinki 34
Des Moines 31
Jinan 31
Buffalo 30
Shenyang 29
São Paulo 29
Brussels 28
Nanchang 28
San Mateo 26
Nuremberg 25
Woodbridge 25
Kunming 23
Marseille 22
Changsha 19
Seoul 19
Toronto 19
Guangzhou 18
Hebei 18
Turku 17
Houston 16
Tianjin 16
Colchester 15
Hangzhou 15
Seattle 15
Tokyo 15
Vienna 15
Belo Horizonte 14
Brooklyn 14
Chicago 14
Falls Church 14
London 14
The Dalles 14
Warsaw 14
Zhengzhou 14
Redmond 13
Rome 13
Atlanta 12
Catania 12
Fontanellato 11
Phoenix 11
Abidjan 10
Bengaluru 10
Biên Hòa 10
Denver 10
Frankfurt am Main 10
Piacenza 10
Rio de Janeiro 10
Tashkent 10
Bremen 9
Haiphong 9
Jakarta 9
Mexico City 9
Pistoia 9
Stockholm 9
Bari 8
Da Nang 8
Norwalk 8
Orem 8
Pune 8
Vicenza 8
Washington 8
Baku 7
Carpi 7
Chennai 7
Curitiba 7
Gravina di Catania 7
Guarulhos 7
Manchester 7
Montreal 7
Newark 7
Ninh Bình 7
Totale 5.952
Salva come PNG Salva come JPEG
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 178
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 176
DNA polymerase [gamma] and disease: what we have learned from yeast 175
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 160
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 160
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 155
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 147
Yeast as a model system to shed light on the role of the human disease protein Mpv17 143
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 143
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 143
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 142
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 142
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 140
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 138
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 137
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 136
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 136
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 135
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 134
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 133
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 133
Yeast as a model system for diseases associated with defective coenzyme a metabolism 132
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 131
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 128
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 125
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 124
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 119
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 119
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 119
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 118
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 117
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 116
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 116
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 115
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 115
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 114
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 113
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 113
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 111
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 109
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 109
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant. 107
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 107
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 107
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 107
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 107
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 106
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 104
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 104
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 103
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 103
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 103
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 102
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 102
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 102
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 101
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 101
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 100
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 100
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 98
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 98
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 97
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 96
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 95
The power of yeast in modeling human mutations leading to mitochondrial disease 95
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 92
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 89
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 88
Epigenetic analyses in forensic medicine: future and challenges 87
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 85
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 84
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 84
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 83
Repurposing Drugs for Mitochondrial Disorders: A Yeast-Based Approach for Complex III Assembly Defects 82
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 81
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 81
Mitochondrial diseases and the role of the yeast models. 80
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 80
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 79
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 79
Role of ROS in mtDNA instability in ANT1-associated adPEO 77
Yeast-based screening to discover therapies for Complex III assembly defects. 76
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 76
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 76
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 75
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 71
Novel (ovario) leukodystrophy related to AARS2 mutations 71
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 70
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 70
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 69
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 69
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 67
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 65
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 63
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 61
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 57
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 55
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 52
From Genetics to Epigenetics: The Steps of a Path 8
Totale 10.376
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021334 0 0 0 0 0 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/20252.559 44 91 123 143 291 388 142 116 359 205 193 464
2025/20263.007 480 529 733 487 743 35 0 0 0 0 0 0
Totale 10.376